Read More Healthcare Industry News Abbott advances coronary artery disease treatment with new intravascular lithotripsy trial Abbott’s Coronary Intravascular Lithotripsy (IVL) System gets FDA approval for a clinical trial to enhance coronary artery disease treatment—learn more. byPallavi MadhirajuMarch 25, 2025